Treatment and timing in invasive mould disease.
| Τίτλος | Treatment and timing in invasive mould disease. |
| Publication Type | Journal Article |
| Year of Publication | 2011 |
| Authors | Maertens, J., Groll A. H., Cordonnier C., de la Cámara R., Roilides E., & Marchetti O. |
| Journal | J Antimicrob Chemother |
| Volume | 66 Suppl 1 |
| Pagination | i37-43 |
| Date Published | 2011 Jan |
| ISSN | 1460-2091 |
| Λέξεις κλειδιά | Antifungal Agents, Chemoprevention, Humans, Immunocompromised Host, Mycoses, Time Factors |
| Abstract | Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed. |
| DOI | 10.1093/jac/dkq440 |
| Alternate Journal | J. Antimicrob. Chemother. |
| PubMed ID | 21177402 |
